McDonnell Boehnen Hulbert & Berghoff LLP partners Paula S. Fritsch, Ph.D. and Andrew W. Williams, Ph.D. co-authored an article entitled, “Some clarity for biosimilar applicants” that appears in the September 2016 online edition of Intellectual Property Magazine. Amgen v Sandoz sought to dispel some of the Biologics Price Competition and Innovation Act’s mystery, but it didn’t go far enough, say the co-authors. View the article
